Special Considerations in the Management of Cardiovascular Disease in the Elderly
To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.
Starts On:
7/1/2018: 12:00 AM
Ends On:
6/30/2019: 12:00 AM
Session Type:
Internet Activity Enduring Material
Credits:
0.5
Description:
Michael W. Rich, MD
Professor, Cardiology Director
Cardiac Rapid Evaluation Unit
Disclosures: No financial relationships to disclose.
Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, Cardiology Update 2017, June 3, 2017.
Edward M. Geltman, MD, FACC
Division of Cardiovascular Diseases
Medical Director, Cardiac Diagnostic Lab
Director, Heart Failure Program
Barnes-Jewish Hospital
Disclosures
Research support/grants from Novartis, Amgen, and Respicardia
Consulting for Novartis
Speakers' Bureau for Amgen
Heidi E. Craddock, FNP, BC
Family Nurse Practitioner, Cardiovascular Division
Disclosures
Consulting for Medtronic and Abbott Laboratories
Speakers' Bureau for Novartis
Philip A. Ludbrook, MD, FACC, FRACP
Professor Emeritus of Medicine and Psychiatry, Cardiovascular Division
Disclosures: No financial relationships to disclose.
Faculty
Michael W. Rich, MD
Professor, Cardiology Director
Cardiac Rapid Evaluation Unit
Disclosures: No financial relationships to disclose.
Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, Cardiology Update 2017, June 3, 2017.
Planning Committee
Edward M. Geltman, MD, FACC
Division of Cardiovascular Diseases
Medical Director, Cardiac Diagnostic Lab
Director, Heart Failure Program
Barnes-Jewish Hospital
Disclosures
Research support/grants from Novartis, Amgen, and Respicardia
Consulting for Novartis
Speakers' Bureau for Amgen
Heidi E. Craddock, FNP, BC
Family Nurse Practitioner, Cardiovascular Division
Disclosures
Consulting for Medtronic and Abbott Laboratories
Speakers' Bureau for Novartis
Philip A. Ludbrook, MD, FACC, FRACP
Professor Emeritus of Medicine and Psychiatry, Cardiovascular Division
Disclosures: No financial relationships to disclose.
Objectives:
The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
- Describe key physiologic changes with ageing
- Explain how to Modify pharmacologic choices appropriately in older patients
Additional Information:
Target Audience: This course is designed for hospitalists, internists, general and family practice physicians, infectious disease physicians, rehabilitation physicians, hospice and palliative physicians, sub-specialty fellows, advanced practice nurses, pharmacists and all allied health professionals who care for hospitalized patients.
Date
Publication Date: July 1, 2018
Expiration Date: June 30, 2019
Target Audience: This course is designed for hospitalists, internists, general and family practice physicians, infectious disease physicians, rehabilitation physicians, hospice and palliative physicians, sub-specialty fellows, advanced practice nurses, pharmacists and all allied health professionals who care for hospitalized patients.
Date
Publication Date: July 1, 2018
Expiration Date: June 30, 2019
Accreditation Information:
In support of improving patient care, this activity has been planned and implemented by the American Heart Association in St. Louis and Washington University School of Medicine in St. Louis. Washington University School of Medicine in St Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Awarded for this Activity:
In support of improving patient care, this activity has been planned and implemented by the American Heart Association in St. Louis and Washington University School of Medicine in St. Louis. Washington University School of Medicine in St Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Awarded for this Activity:
Credit Statement:
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™. Learners should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC Credit)
This activity is awarded up to .5 ANCC contact hour.
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .5 AMA PRA Category 1 Credit™. Learners should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC Credit)
This activity is awarded up to .5 ANCC contact hour.
References:
- Circulation 2000;102(Suppl II):II-602
- CMS administrative claims data, January - December 2010,
accessed from the Chronic Condition Warehouse (CCW) at www.cms.gov - J Gerontol Med Sci 2001;56:M46-56
- J Cardiac Failure 2011;17:217-223
- Braunwald's Heart Disease, 9th ed., p. 1732
- Eur Heart J 2012;33:752-9
Disclosure Information:
It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
